ComplianceOnline

Assessment of Abuse Potential of Drugs - Guidance for Industry

  • By: Staff Editor
  • Date: February 07, 2017
Webinar All Access Pass Subscription Abstract:

Assessment of Abuse Potential of Drugs - Guidance for Industry

Abuse-Deterrent Opioids (Evaluation and Labeling) - Guidance for Industry

With the intent to assist applicants who seek approval for a new drug, particularly to evaluate the abuse potential of the drug, and to assist sponsors of investigational new drugs, these FDA guidance seek to offer insight into key decision points such as recommended studies in assessing abuse potential, cases when abuse-related studies should be conducted, preparing the NDA submission, NDA review and product labeling related to abuse potential, and the drug scheduling process.

Bookmark and Share
Best Sellers
You Recently Viewed
    Loading